-
Magnolia Health Urges Breast Cancer Screenings After Delays Due to COVID-19 Pandemic
prnewswire
October 29, 2020
As healthcare facilities across Mississippi resume scheduling routine appointments and screenings, Magnolia Health (Magnolia) wants to remind communities of the importance of taking care of their health.
-
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
prnewswire
October 29, 2020
Ampio Pharmaceuticals, Inc., a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced the Company has begun recruiting and enrolling patients in ...
-
EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe
prnewswire
October 29, 2020
Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI plc, and manufacturing partner Bio-Techne Corporation, entered into a two-year marketing and distribution agreement with EKF Diagnostics ...
-
Pathnostics Launches Single Test to Detect COVID-19, Flu and RSV
prnewswire
October 29, 2020
Pathnostics announced that it has launched a multiplex polymerise chain reaction (PCR) test that simultaneously detects multiple respiratory infections, including COVID-19, influenzas A/B and respiratory syncytial virus (RSV).
-
TrippBio Completes Trial Enrollment to Evaluate Efficacy of TD213 for COVID-19
americanpharmaceuticalreview
October 29, 2020
TrippBio is developing a patent-pending repurposed FDA-approved drug, TD213. TD213 works by blocking the SARS-CoV-2 virus' replication and the associated acute inflammatory response to the infection.
-
Sotira Finds Preliminary Success Developing Intranasal COVID-19 Vaccine Alternative
americanpharmaceuticalreview
October 29, 2020
Sotira has announced preliminary findings of preclinical safety and efficacy studies for its patent-pending vaccine alternative that has shown in on-going preclinical testing to attenuate COVID-19 infection.
-
Italy gives approval to trial osteoporosis drug for Covid-19 treatment
pharmaceutical-technology
October 29, 2020
The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to treat paucisymptomatic Covid-19 patients.
-
Piramal Pharma’s consumer division launches Tri-Activ disinfectant spray for COVID-19
expresspharma
October 29, 2020
The company claims that for multi-surfaces it is “99.9 per cent effective against the COVID-19 virus in one minute.
-
Lilly, U.S. Govt. Enter Supply Pact for Bamlanivimab COVID-19 Treatment
contractpharma
October 29, 2020
Initial agreement is for 300,000 vials of the investigational neutralizing antibody with potential for purchase of an additional 650,000 vials.
-
Cipla launches ELIFast for COVID-19 antibody detection
expresspharma
October 29, 2020
Cipla announced the commercialisation of antibody detection kits for COVID-19 in India. It is in partnership with KARWA under the technology transfer from the Indian Council of Medical Research (ICMR).